Imo this was a buy or build decision. SW1 have the cashflow and means available to invest in the internal development of the ad platform and capability, but it would mean hiring a team, investing in the tech, establishing relationships with content advertisers and rolling out with customers. That all in all could be a multi-year, multi-million dollar commitment and wouldn't guarantee results right away.
The path they've taken is the buy approach. They get the team, the tech, established relationships and revenues, so it's ready to integrate with the broader Swift business and roll out. Fast tracks a few years of 'build' time.
Overall my impression is that the vendors have gotten themselves an extremely good deal here. The upfront consideration is reasonable, however the performance based milestones to me seem pretty weak relative to the large payout they will receive. It's hard to make an objective assessment of this acquisition without the full insight the management team have to both the potential of MM/it's integration with Swift, and the internal assessment of just how costly/time consuming/risky the 'build' approach would be. From my vantage point though this is another large issue of performance shares to an already shakey register that is continually under sell pressure.
I'm pleased they are advancing the business and really building a robust engine for growth, but given the transaction terms I would really like to see the management team engage with market participants to tighten up the share register so we can see some meaningful share price recognition for the strong performance of the business itself.
- Forums
- ASX - By Stock
- SW1
- Ann: Swift Buys Digital-Out-Of-Home Media Network, Medical Media
Ann: Swift Buys Digital-Out-Of-Home Media Network, Medical Media, page-19
-
- There are more pages in this discussion • 8 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add SW1 (ASX) to my watchlist
(20min delay)
|
|||||
Last
1.0¢ |
Change
-0.002(16.7%) |
Mkt cap ! $9.810M |
Open | High | Low | Value | Volume |
1.0¢ | 1.1¢ | 1.0¢ | $10.15K | 1.000M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
5 | 830362 | 0.9¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
1.0¢ | 140143 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 199996 | 0.013 |
2 | 691666 | 0.012 |
1 | 226370 | 0.011 |
1 | 100000 | 0.010 |
1 | 120000 | 0.008 |
Price($) | Vol. | No. |
---|---|---|
0.016 | 531250 | 1 |
0.018 | 462860 | 1 |
0.019 | 1000000 | 1 |
0.020 | 218562 | 1 |
0.021 | 70000 | 1 |
Last trade - 15.48pm 25/11/2024 (20 minute delay) ? |
Featured News
SW1 (ASX) Chart |
The Watchlist
ACW
ACTINOGEN MEDICAL LIMITED
Andy Udell, CCO
Andy Udell
CCO
SPONSORED BY The Market Online